Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Differentiated by Clinical Trials, World-Class Management

NEXT STORY
Historic Comprehensive Anti-Horse Slaughter Transport Amendment Passes U.S. House
PREV STORY
Adverum Announces Appointment of Jon Williams, Ph.D., as Vice President, Clinical Affairs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TG Therapeutics Announces Orphan Drug Designation for TG-1101 for the Treatment of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder

NEW YORK, Aug. 26, 2016 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that ...

author_avatar
NASDAQ Market News

TESARO Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass., Nov. 15, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that ...

author_avatar
NASDAQ Market News

OPKO Health Provides Commercial Update for RAYALDEE

Approximately 68% of all insured lives now have access to RAYALDEEOn track to reach ...

author_avatar
NASDAQ Market News